Загрузка...
Enabling and disabling Polo-like kinase 1 inhibition through chemical genetics
Polo-like kinase 1 (Plk1) is a core regulator of cell division and an emerging target for cancer therapy. Pharmacologic inhibitors of Plk1 exist but affect other kinases complicating their in vivo validation. To address this, we examined effects of two structurally unrelated Plk1 inhibitors (BI-2536...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3376236/ https://ncbi.nlm.nih.gov/pubmed/22422077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cb200551p |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|